These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12786629)

  • 21. Current best practice for disease activity assessment in IBD.
    Walsh AJ; Bryant RV; Travis SP
    Nat Rev Gastroenterol Hepatol; 2016 Oct; 13(10):567-79. PubMed ID: 27580684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of a mutant of keratinocyte growth factor-2 on trinitrobenzene sulfonic acid-induced rat model of Crohn's disease.
    Wang J; Chen H; Wang Y; Cai X; Zou M; Xu T; Wang M; Wang J; Xu D
    Am J Transl Res; 2016; 8(2):530-43. PubMed ID: 27158345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
    J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.
    Nalle SC; Turner JR
    Mucosal Immunol; 2015 Jul; 8(4):720-30. PubMed ID: 25943273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.
    Rowland KJ; Choi PM; Warner BW
    Semin Pediatr Surg; 2013 May; 22(2):101-11. PubMed ID: 23611614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds.
    Plichta JK; Radek KA
    J Burn Care Res; 2012; 33(3):299-310. PubMed ID: 22561305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we protect the gut in critical illness? The role of growth factors and other novel approaches.
    Dominguez JA; Coopersmith CM
    Crit Care Clin; 2010 Jul; 26(3):549-65, x. PubMed ID: 20643306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.
    Barahona-Garrido J; Hernández-Calleros J; García-Juárez I; Yamamoto-Furusho JK
    Saudi J Gastroenterol; 2009; 15(3):208-12. PubMed ID: 19636186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FGF family: biology, pathophysiology and therapy.
    Beenken A; Mohammadi M
    Nat Rev Drug Discov; 2009 Mar; 8(3):235-53. PubMed ID: 19247306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of inflammatory bowel disease: a review of medical therapy.
    Kozuch PL; Hanauer SB
    World J Gastroenterol; 2008 Jan; 14(3):354-77. PubMed ID: 18200659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of the placebo response in ulcerative colitis.
    Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
    Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease.
    Ido A; Numata M; Kodama M; Tsubouchi H
    J Gastroenterol; 2005 Oct; 40(10):925-31. PubMed ID: 16261428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical therapy for ulcerative colitis: the state of the art and beyond.
    Ross AS; Cohen RD
    Curr Gastroenterol Rep; 2004 Dec; 6(6):488-95. PubMed ID: 15527679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologics in inflammatory bowel disease: how much progress have we made?
    Sandborn WJ; Faubion WA
    Gut; 2004 Sep; 53(9):1366-73. PubMed ID: 15306602
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of growth factors and receptor blockade on gastrointestinal cancer.
    Playford RJ; Wassan H; Ghosh S
    Gut; 2004 Aug; 53(8):1059-63. PubMed ID: 15247165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing Therapy on the Basis of Disease Classifications in Inflammatory Bowel Disease.
    Abreu MT
    Curr Treat Options Gastroenterol; 2004 Jun; 7(3):169-179. PubMed ID: 15149579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Sandborn WJ; Sands BE; Wolf DC; Valentine JF; Safdi M; Katz S; Isaacs KL; Wruble LD; Katz J; Present DH; Loftus EV; Graeme-Cook F; Odenheimer DJ; Hanauer SB
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1355-64. PubMed ID: 12786629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
    Vermeire S; Sandborn WJ; Danese S; Hébuterne X; Salzberg BA; Klopocka M; Tarabar D; Vanasek T; Greguš M; Hellstern PA; Kim JS; Sparrow MP; Gorelick KJ; Hinz M; Ahmad A; Pradhan V; Hassan-Zahraee M; Clare R; Cataldi F; Reinisch W
    Lancet; 2017 Jul; 390(10090):135-144. PubMed ID: 28527704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.